News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
144
Sources here
21
Companies here
10
Search results Stored financial headlines

Active search

144 matching headlines

Ticker or company: TEPMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stepan faces earnings test as restructuring plan unfolds By Investing.com

Stepan Company is set to release its second-quarter earnings, with analysts anticipating improved profitability driven by a cost-reduction program called Project Catalyst. Investors will be closely watching the progress of this restructuring plan, margin trends, and volume momentum across end markets. Despite a turbulent …

SCL main company
Sharemaestro market context Trend signal active 52 weeks +29.6% SCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TP Expands Operations in Brownsville With 300+ New Jobs and Second Operations Center

BROWNSVILLE, Texas, July 28, 2026--(BUSINESS WIRE)--Global digital business services leader TP (ex-Teleperformance) today announced the company is expanding its operations in Brownsville, Texas, with the opening of a second operations center and more than 300 new jobs. The new Brownsville BTX center spans 30,229 …

TEP main company TEP main company
Sharemaestro market context Trend signal active 52 weeks +2.8% · Next-week setup negative 34.6% TEP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stepan Co (SCL) Valuation: PE, PB & Fair Value Analysis

Stepan Co (SCL) currently holds a valuation score of 8.90, ranking 16th out of 65 companies in the Chemicals industry. Its P/E ratio is -92.70, which is significantly below its recent high and slightly above its recent low. Other key valuation metrics like P/B, …

SCL main company
Sharemaestro market context Trend signal active 52 weeks +29.6% SCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep Ltd Sponsored ADR Revenue Breakdown – FWB:YP1A

The article provides a financial overview and market data for Immutep Ltd Sponsored ADR (FWB:YP1A) on the Frankfurt Stock Exchange. It highlights the company's financial statements, statistics, dividends, earnings, and segments, indicating a focus on its fundamental performance. No specific revenue breakdown figures are …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SCL|Stepan Co|Price:57.500|Chg%:-0.070

This article provides a comprehensive stock analysis of Stepan Co (SCL) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation, ranking 12th in the Chemicals industry. Despite positive analyst ratings and institutional confidence, technical indicators suggest sideways trading. The analysis covers …

SCL main company
Sharemaestro market context Trend signal active 52 weeks +29.6% SCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

IMMP|Immutep Ltd|Price:0.385|Chg%:-0.008

This article provides an overview of Immutep Ltd (IMMP) with its current stock price and change percentage. It details how TradingKey generates its stock scores, covering dimensions like financial health, company valuation, earnings forecasts, price momentum, institutional confidence, and risk management. However, it notes …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

StepStone Group schedules its next results webcast for Aug. 6

StepStone Group (NASDAQ: STEP) announced it will release its financial results for the first quarter of fiscal year 2027, covering the period ended June 30, 2026, after the market closes on Thursday, August 6, 2026. Management will host a webcast and conference call at …

STEP main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 58.2% STEP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

STEP | StepStone Group Inc. Class Executive Compensation

This article provides an overview of executive compensation for StepStone Group Inc. (STEP), noting that the highest-paid executive received an estimated compensation of -- in --. It also estimates the median employee salary at $177,731. The page further offers various financial data, institutional holdings, …

STEP main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 58.2% STEP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep Ltd (IMMP) Institutional Confidence

The article provides an overview of Immutep Ltd's (IMMP) institutional confidence based on shareholding data. It lists several institutional investors, their shareholdings, and the percentage change in their positions. Key investors include BlackRock Institutional Trust Company, N.A., UBS Financial Services, Inc., and Millennium Management …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stepan Co (SCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a brief overview of Stepan Co (SCL)'s stock performance and a breakdown of its revenue by geographic region. The company's market capitalization is $1.30 billion, and its stock price is $57.570. The regional revenue data indicates that the United States contributes …

SCL main company
Sharemaestro market context Trend signal active 52 weeks +29.6% SCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep Ltd Revenue Breakdown – SWB:YP1B

The article provides a revenue breakdown for Immutep Ltd (SWB:YP1B) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segment performance. The page also prominently displays various navigation elements and links to TradingView's extensive features and community …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stepan Co (SCL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Stepan Co (SCL), identifying major institutional holders like BlackRock, Hightower Advisors, and Vanguard. It breaks down shareholder types by proportion, showing investment advisors as the largest category. The report also includes historical institutional shareholding data and lists …

SCL main company
Sharemaestro market context Trend signal active 52 weeks +29.6% SCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep Ltd (IMMP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical dividend and stock split information for Immutep Ltd (IMMP). It indicates that Immutep Ltd has distributed a total of $0.00 in dividends over the past 5 years and currently has no data available for dividend dates. The article also includes …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

StepStone Group Inc. SEC Filing (Jul 21, 2026)

This article reports on an ARS filing by StepStone Group Inc. (NASDAQ: STEP) on July 21, 2026, which was accepted by the SEC EDGAR system. The filing is an ARS type, indicating a low impact and neutral sentiment. The article also provides a brief …

STEP main company STEP main company
Sharemaestro market context Price below Trend Line 52 weeks -36.3% · Next-week setup negative 19.7% STEP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep Ltd (IMMP) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Immutep Ltd (IMMP), detailing its stock performance and key financial metrics like Market Cap. It notes that relevant data for P/E, P/B, P/S, and P/CF ratios have not yet been disclosed by the company. The overview includes …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep Ltd (IMMP) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Immutep Ltd (IMMP), detailing its volatility, financial risk, and investment risk metrics. Key data points include beta, VaR, maximum drawdown, and various volatility and liquidity measures over different periods. The information is intended to help investors understand …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stepan Company (SCL) Stock Forecasts

Argus has raised its target price for Stepan Company (SCL) to $62.00. The company, which manufactures and sells chemicals and chemical-based products across three segments, currently trades at $58.57. This update comes with an invitation for users to upgrade to premium for more detailed …

SCL main company
Sharemaestro market context Trend signal active 52 weeks +29.6% SCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Immutep Limited announced that an abstract for its investigator-initiated EFTISARC-NEO Phase II trial has been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2026. The abstract will report health-related quality of life (HRQoL) data from the trial, which evaluates eftilagimod …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep's Eftilagimod Alfa Quality of Life Findings Approved for ESMO Congress 2026 in Madrid

Immutep Limited (ASX: IMM; NASDAQ: IMMP) announced that an abstract detailing health-related quality of life outcomes from its EFTISARC-NEO Phase II trial has been accepted for presentation at the ESMO Congress 2026 in Madrid. The trial investigates eftilagimod alfa in combination with pembrolizumab and …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep's Eftilagimod Alfa Quality of Life Data Accepted for ESMO Congress 2026 Presentation

Immutep Limited announced that its abstract on health-related quality of life outcomes from the EFTISARC-NEO Phase II trial has been accepted for presentation at the ESMO Congress 2026 in Madrid. This trial evaluates eftilagimod alfa, a first-in-class MHC Class II agonist, in combination with …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stepan stock reflects steady specialty chemical growth after mixed 2024 results

Stepan Company reported mixed results for 2024, with net sales declining to $2.0 billion from $2.2 billion in 2023, while profitability and cash generation improved. The specialty chemicals group saw increased adjusted net income and operating margin, supported by a richer product mix, cost …

SCL main company
Sharemaestro market context Trend signal active 52 weeks +29.6% SCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stepan Company (SCL) Q1 2024 Earnings Report - Results, Call & Slides

Stepan Company (SCL) reported its Q1 2024 earnings, showing an actual EPS of $0.64, beating the consensus estimate of $0.35 by $0.29. However, the company missed revenue expectations, reporting $551.42 million against an expected $575.83 million, marking a 15.35% year-over-year decline. The earnings call …

SCL main company
Sharemaestro market context Trend signal active 52 weeks +29.6% SCL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

What StepStone Group (STEP)'s Strong Quarter And Reaffirmed Dividend Mean For Shareholders

StepStone Group (STEP) recently announced strong quarterly results and reaffirmed its dividend, despite facing a decline in revenue and a net loss of US$535.81 million. While management has shown a willingness to return capital through dividends and buybacks, the company's ongoing losses and insider …

STEP main company
Sharemaestro market context Price above Trend Line 52 weeks -15.6% · Next-week setup positive 58.2% STEP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Immutep highlights encouraging survival data and key clinical milestones

Immutep (ASX: IMM; Nasdaq: IMMP) CEO Marc Voigt discussed positive overall survival data from the INSIGHT-003 trial, where patients achieved over 30 months of median overall survival. He also provided an update on the ongoing root cause analysis for the TACTI-004 Phase III trial …

IMMP main company
Sharemaestro market context Price below Trend Line 52 weeks -78.5% IMMP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context